triptolide has been researched along with Adenocarcinoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blazar, BR; Cuellar, RA; Georg, GI; Gurvich, VJ; Lis, LG; Morgan, ML; Norris, BJ; Patil, S; Schumacher, RJ; Suryanarayanan, R | 1 |
| Gao, R; Qiu, H; Shen, T; Shi, J; Yu, H; Zhang, X | 1 |
| Jin, X; Li, F; Liu, Q; Wang, J; Wang, W; Yang, S; Zhao, D | 1 |
| Li, J; Qi, Y | 1 |
| Chai, K; Jiang, K; Li, F; Meng, G; Wang, W; Yang, S | 1 |
| Banerjee, S; Dudeja, V; McGinn, O; Modi, S; Ramakrishnan, S; Saluja, AK; Zhao, X | 1 |
| Liu, G; Liu, H; Ma, T; Zhang, X | 1 |
| Dong, XP; Jiang, N; Jiang, XT; You, QY; Zhang, SL; Zhao, XG | 1 |
| Borja-Cacho, D; Chugh, RK; Clawson, KA; Dawra, RK; Dudeja, V; Mujumdar, NR; Saluja, AK; Vickers, SM; Yokoyama, Y | 1 |
| Cheng, JP; Ding, XL; Huang, JF; Wei, Q; Wu, SB; Zhang, H; Zhou, GX | 1 |
10 other study(ies) available for triptolide and Adenocarcinoma
| Article | Year |
|---|---|
Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colon; Colonic Neoplasms; Diterpenes; Drug Stability; Epoxy Compounds; Female; HT29 Cells; Humans; Mice; Mice, Nude; Organophosphates; Ovarian Neoplasms; Ovary; Phenanthrenes; Prodrugs; Solubility | 2015 |
Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Computational Biology; Databases, Genetic; Diterpenes; Epoxy Compounds; Humans; Phenanthrenes; Prognosis; Protein Interaction Maps; Stomach Neoplasms; Transcriptome; Tumor Microenvironment | 2021 |
ITRAQ-Based Proteomics Analysis of Triptolide On Human A549 Lung Adenocarcinoma Cells.
Topics: A549 Cells; Adenocarcinoma; Apoptosis; Chromatography, High Pressure Liquid; Diterpenes; Drugs, Chinese Herbal; Epoxy Compounds; G2 Phase Cell Cycle Checkpoints; Humans; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Nanotechnology; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Protein Interaction Maps; Proteome; Proteomics; Proto-Oncogene Proteins c-akt; Signal Transduction; Tandem Mass Spectrometry; Tripterygium | 2018 |
RETRACTED: Triptolide inhibits the growth and migration of colon carcinoma cells by down-regulation of miR-191.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Diterpenes; Down-Regulation; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Phenanthrenes; Xenograft Model Antitumor Assays | 2019 |
Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcineurin; Camptothecin; Cell Line, Tumor; Diterpenes; Drug Synergism; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Humans; Irinotecan; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; Phenanthrenes; Proto-Oncogene Proteins c-akt; Signal Transduction | 2015 |
Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Diterpenes; Drug Delivery Systems; Epoxy Compounds; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Organophosphates; Pancreatic Neoplasms; Phenanthrenes; Stromal Cells; Tumor Microenvironment | 2016 |
[Sequence-dependent Effect of Triptolide with Gefitinib on the Proliferation
and Apoptosis of Lung Adenocarcinoma Cell H1975].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diterpenes; Epoxy Compounds; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Phenanthrenes; Protein Kinase Inhibitors; Quinazolines | 2015 |
Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Diterpenes; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasm Proteins; NF-kappa B; Paclitaxel; Phenanthrenes; S Phase; Signal Transduction; Time Factors | 2016 |
TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Survival; Diterpenes; Epoxy Compounds; Humans; Pancreatic Neoplasms; Phenanthrenes; TNF-Related Apoptosis-Inducing Ligand | 2010 |
Apoptosis of human pancreatic cancer cells induced by Triptolide.
Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Diterpenes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Time Factors; Tripterygium; Up-Regulation | 2008 |